Skip to main content

The leading edge of active surveillance for patients and urologists

Renowned Cleveland Clinic Urologist Dr. Eric Klein discusses Active Surveillance.
Dr. Klein answers the questions: “What do I actually do while I’m on Active Surveillance?” What tests should I be taking and how often? How do I know if I qualify for Active Surveillance? What indicators will tell me that I must go off Active Surveillance and seek active treatment? Dr. Klein indicated that 15% of Gleason 6s have a molecular make up which may indicate the presence of a more aggressive cancer and in his opinion, genomic testing is critical to identify those cancers.

If you would like to view Dr. Klein’s slides click here: AS Overview July 31 2021

Share this: